913 related articles for article (PubMed ID: 18663165)
21. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
Brunetti L; Campbell RK
J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819
[TBL] [Abstract][Full Text] [Related]
22. Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose.
Davidson MH; Rooney M; Pollock E; Drucker J; Choy Y
J Clin Lipidol; 2013; 7(5):423-32. PubMed ID: 24079283
[TBL] [Abstract][Full Text] [Related]
23. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Pei D; Hsieh CH; Hung YJ; Li JC; Lee CH; Kuo SW
Metabolism; 2006 Jul; 55(7):923-7. PubMed ID: 16784965
[TBL] [Abstract][Full Text] [Related]
24. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
Knopp RH; Tsunehara C; Retzlaff BM; Fish B; Nguyen H; Anderson S; Nguyen T
Metabolism; 2006 Dec; 55(12):1697-703. PubMed ID: 17142146
[TBL] [Abstract][Full Text] [Related]
26. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
27. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.
Bosi E; Camisasca RP; Collober C; Rochotte E; Garber AJ
Diabetes Care; 2007 Apr; 30(4):890-5. PubMed ID: 17277036
[TBL] [Abstract][Full Text] [Related]
28. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
Levy P
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
[TBL] [Abstract][Full Text] [Related]
29. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
[TBL] [Abstract][Full Text] [Related]
30. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
[TBL] [Abstract][Full Text] [Related]
31. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of colesevelam in combination with pioglitazone in patients with type 2 diabetes mellitus.
Rosenstock J; Truitt KE; Baz-Hecht M; Ford DM; Tao B; Chou HS
Horm Metab Res; 2014 Dec; 46(13):943-9. PubMed ID: 25054436
[TBL] [Abstract][Full Text] [Related]
33. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
35. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients.
Hwang YC; Lee EY; Lee WJ; Cha BS; Yoon KH; Park KS; Lee MK
Metabolism; 2008 Apr; 57(4):479-87. PubMed ID: 18328348
[TBL] [Abstract][Full Text] [Related]
36. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Simons WR; Hagan MA
Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
[TBL] [Abstract][Full Text] [Related]
38. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
39. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.
Kim D; MacConell L; Zhuang D; Kothare PA; Trautmann M; Fineman M; Taylor K
Diabetes Care; 2007 Jun; 30(6):1487-93. PubMed ID: 17353504
[TBL] [Abstract][Full Text] [Related]
40. Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes.
Avitabile N; Banka A; Fonseca VA
Expert Opin Drug Saf; 2011 Mar; 10(2):305-10. PubMed ID: 21244342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
